Oxbridge Re (NASDAQ:OXBR – Get Free Report) is expected to be releasing its Q3 2026 results after the market closes on Monday, November 9th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $0.40 million for the quarter. Individuals may visit the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Monday, November 9, 2026 at 4:30 PM ET.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The insurance provider reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.01). The firm had revenue of $0.94 million for the quarter, compared to analyst estimates of $1.10 million. Oxbridge Re had a return on equity of 2.14% and a net margin of 4.71%. On average, analysts expect Oxbridge Re to post ($0.08) EPS for the current fiscal year and ($0.18) EPS for the next fiscal year.
Oxbridge Re Price Performance
OXBR stock opened at $0.73 on Monday. The firm has a market cap of $5.96 million, a price-to-earnings ratio of 36.61 and a beta of 2.00. The company’s fifty day simple moving average is $1.19 and its 200 day simple moving average is $1.11. Oxbridge Re has a 12-month low of $0.65 and a 12-month high of $1.86.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on OXBR
About Oxbridge Re
Oxbridge Re Holdings Limited is a specialty reinsurance holding company listed on the Nasdaq Capital Market under the symbol OXBR. The company conducts its reinsurance activities primarily through Oxbridge Reinsurance Limited, a Bermuda-based subsidiary, and focuses on providing collateralized property catastrophe reinsurance.
Its coverage is designed to protect insurance companies against losses from major natural-catastrophe events, including hurricanes and other severe weather-related disasters.
See Also
- Five stocks we like better than Oxbridge Re
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
